ARCHIVES

Sloan-Kettering Sues Empire Blue Cross Over Reimbursement

This article is from The Cancer Letter archive.

Vol. 19 No. 36 | September 17, 1993

Download PDF Visit The Full Archive

Related Articles

Academic Oncologists Losing Control Over Phase I Trials As For-Profits Expand

March 26, 2010

Consensus Conference agrees That Nevi Can Be Precursors For Melanoma, Offers Management Suggestions

November 4, 1983

Okunieff To Lead SWOG Radiation Committee

July 19, 2002

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

Groups Advise NCI On “Investment Opportunities”

June 28, 1996

Symposium to Focus on New Approaches to Drug Resistance

May 11, 1990